Evolent Health (EVH) Tops Q3 EPS by 24c

Evolent Health (NYSE: EVH) reported Q3 EPS of $0.11, $0.24 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $60.2 million versus the consensus estimate of $58.35 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth
• Braze stock tumbles 10% on weak third quarter EPS guidance